financetom
Business
financetom
/
Business
/
Monkey with Neuralink chip plays videogame with its mind. Know all about the technology
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Monkey with Neuralink chip plays videogame with its mind. Know all about the technology
Apr 10, 2021 6:45 AM

Neuralink, the brain chip start-up of Tesla CEO Elon Musk, on Friday shared a video in which a monkey was seen playing a video game following the implants of the new technology. Neuralink shared the YouTube link to the video and a note explaining the process in the next tweet.

Pager, the macaque monkey, has Neuralink chips implanted on each side of his brain and he plays “Mind Pong” with utmost ease. The narrator says that the money had a Neuralink implanted six weeks before the video was shot. Interestingly, Pager was trained to play it using a joystick, which is now unplugged, and now he controls the paddle simply by thinking about the direction he wants to move the joystick in.

Musk tweeted that the first Neuralink product will allow someone with paralysis to use a smartphone with their mind faster than someone using thumbs. "The device is implanted flush with skull & charges wirelessly, so you look & feel totally normal," he added in another tweet.

First @Neuralink product will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs

— Elon Musk (@elonmusk) April 9, 2021

The device is implanted flush with skull & charges wirelessly, so you look & feel totally normal

— Elon Musk (@elonmusk) April 9, 2021

What is Neuralink?

In simple words, Neuralink is a technology that helps human brains interact with machines and control them by sending and receiving signals directly. The N1 chipset, which is 8 mm in diameter containing multiple wires housing electrodes and insulation for the wires, will be installed in your skull surgically. It will then help the human communicate with machines and control them merely by thinking about the steps to take.

How does it work?

For this, let's get to the basics. What does our brain do? Our brain contains billions of nerve cells and they coordinate our thoughts, emotions, behaviour, movements, and sensation. And these nerve cells, which form part of a larger system, contribute to sending immediate signals to different parts of the body, prompting us to respond to the situation as it unfolds before our eyes.

Similarly, the Neuralink technology, once installed in our brains, will be able to read what we are thinking and help us control the machines without even touching them or giving them any verbal instructions.

How will it be installed?

This is the tricky part. Since we are talking about installing a chipset, no matter how small, into a human brain. Not only has this raised concern among people but also made them think if it was even possible. Elon Musk acknowledges the complexity of the matter and says such an installation was beyond the capabilities of human hands.

And therefore, the technology will involve the usage of specially developed robots that will carry out the precise installation of chips into the cortex, the outer covering of the surfaces of the cerebral hemispheres.

What are the concerns?

Despite what sounds and looks revolutionary, no technology, especially with artificial intelligence (AI) being the front and centre, is immune to hazards. First, the device has shown a great response on Pager, but no human trial has been carried out, not yet.

One of the major concerns is that of hacking. If the device remains connected to the internet all the time, what's the guarantee that hackers won't attempt to influence or steal the data or even snooping on our thoughts?

Such a device can’t stay in the human brain forever, right? For how long then will it remain there? Elon Musk says it will have the option of removing it, but Neuralink is looking at keeping it for at least 10 years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives
Apr 25, 2024
April 25 (Reuters) - Altria Group ( MO ) topped quarterly sales expectations on Thursday, driven by higher pricing and rising demand for alternatives to conventional tobacco products. Like other tobacco giants, Altria ( MO ) has been revamping its portfolio of products to keep up with consumers switching from traditional tobacco products to vapes or other alternatives and as...
Star Diamond and Minespider Launch G7-Compliant
Star Diamond and Minespider Launch G7-Compliant "Diamond Passport"
Apr 25, 2024
08:15 AM EDT, 04/25/2024 (MT Newswires) -- Star Diamond ( SHGDF ) and Minespider, a traceability platform for tracking minerals and raw materials, said on Thursday that they launched the Diamond Passport to comply with new G7 rules. The passport contains all key information about the diamond, including its provenance data, the diamond's unique DNA, such as size, shape, color,...
Amazon to invest $11 billion in Indiana to build data centers
Amazon to invest $11 billion in Indiana to build data centers
Apr 25, 2024
(Reuters) - Amazon.com's ( AMZN ) cloud-computing arm said it would invest $11 billion in Indiana to build data centers, marking the state's largest capital investment, and promising at least 1,000 jobs. The announcement by Amazon Web Services on Thursday builds on the online retail giant's already strong presence in the state, where it employs 26,000 full- and part-time staff....
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Apr 25, 2024
April 25 (Reuters) - AbbVie ( ABBV ) said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition showed superior efficacy to Regeneron Pharmaceuticals ( REGN ) and Sanofi's Dupixent in a late-stage head-to-head study. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved